These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15736468)

  • 1. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma.
    Visca P; Sebastiani V; Botti C; Diodoro MG; Lasagni RP; Romagnoli F; Brenna A; De Joannon BC; Donnorso RP; Lombardi G; Alo PL
    Anticancer Res; 2004; 24(6):4169-73. PubMed ID: 15736468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
    Visca P; Sebastiani V; Pizer ES; Botti C; De Carli P; Filippi S; Monaco S; Alo PL
    Anticancer Res; 2003; 23(1A):335-9. PubMed ID: 12680233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of fatty acid synthase expression in non-small cell lung cancer].
    Wang Y; Zhang X; Tan W; Fu J; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):271-3. PubMed ID: 12515624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma.
    Alo PL; Amini M; Piro F; Pizzuti L; Sebastiani V; Botti C; Murari R; Zotti G; Di Tondo U
    Anticancer Res; 2007; 27(4B):2523-7. PubMed ID: 17695548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
    Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma.
    Kawamura T; Kanno R; Fujii H; Suzuki T
    Pathobiology; 2005; 72(5):233-40. PubMed ID: 16374067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung.
    Allen TC; Granville LA; Cagle PT; Haque A; Zander DS; Barrios R
    Hum Pathol; 2007 Feb; 38(2):220-7. PubMed ID: 17234469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes.
    Silva SD; Perez DE; Alves FA; Nishimoto IN; Pinto CA; Kowalski LP; Graner E
    Oral Oncol; 2008 May; 44(5):484-90. PubMed ID: 17825601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of fatty acid synthase for lung cancer treatment.
    Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
    Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin expression and prognostic significance in non-small cell lung cancer.
    Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
    Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
    Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
    Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
    Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.